| |
|
No. (%) |
| Sex |
Male |
29 (50) |
| |
Female |
29 (50) |
| Age |
Mean |
81.4 |
| |
Median |
83.0 |
| Race |
Caucasian |
47 (81) |
| |
Other |
11 (19) |
| Smoking Status |
Active Smoker |
15 (25.8) |
| |
Ex-Smoker |
34 (58.6) |
| |
Never Smoker |
5 (8.6) |
| |
Unknown |
4 (6.8) |
| Disease Status at Follow-up |
No evidence of disease |
26 (44.8) |
| |
Recurrent disease |
30 (51.7) |
| |
Unknown |
2 (3.4) |
| Cause of Death (n=46) |
Death from lung cancer |
27 (58.7) |
| |
Death from other cancer |
2 (4.3) |
| |
Death from other causes |
14 (30.4) |
| |
Unknown |
3 (6.5) |
| Tumor Histology |
Adenocarcinoma |
23 (36.2) |
| |
Squamous Cell |
21 (36.2) |
| |
Large Cell |
3 (6.4) |
| |
Other NSCLC |
11 (18.9) |
| Tumor Stage |
IA |
23 (39.6) |
| |
IB |
35 (60.3) |
| Tumor Grade (Differentiation) |
Poor |
30 (51.7) |
| |
Well to Moderate |
25 (43.1) |
| |
Unknown |
3 (5.2) |
|
